Medical marijuana legislation gets support of key House Republican

Medical marijuana legislation gets support of key House Republican

House Judiciary Committee Chairman Bob GoodlatteRobert (Bob) William GoodlatteFormer FBI lawyer Lisa Page gets closed-door grilling from House Republicans 5 takeaways from wild hearing with controversial FBI agent GOP lawmaker asks FBI agent about lying to wife over affair MORE (R-Va.) has signed on to co-sponsor bipartisan legislation to simplify the medical marijuana research process. 

Goodlatte's spokeswoman, Kathryn Rexrode, told Bloomberg that Goodlatte would co-sponsor the bill with Rep. Matt GaetzMatthew (Matt) GaetzSacha Baron Cohen mulls arming toddlers with guns in inaugural episode Who to watch for in Sacha Baron Cohen's upcoming show GOP lawmaker thinks he was duped by Sacha Baron Cohen MORE (R-Fla.). 

ADVERTISEMENT
Gaetz on Tuesday was reportedly sending around a handout explaining his Medical Cannabis Research Act, which listed the Virginia Republican as a co-sponsor. 

A spokesman for the Florida congressman told Bloomberg that the bill was set to be introduced on Tuesday or Wednesday, and a news conference would be held by its sponsors. 

Two U.S. senators earlier this month called on Attorney General Jeff SessionsJefferson (Jeff) Beauregard SessionsConservatives moving to impeach Rosenstein soon: report Senators urge DOJ to probe whether Russians posed as Islamic extremist hackers to harass US military families The Hill's Morning Report — Trump readies for Putin summit: 'He’s not my enemy’ MORE to stop efforts by the by the Drug Enforcement Agency (DEA) to slow medical marijuana research.

“Research on marijuana is necessary for evidence-based decision making, and expanded research has been called for by President Trump’s Surgeon General, the Secretary of Veterans Affairs, the FDA, the CDC, the National Highway Safety Administration, the National Institute of Health, the National Cancer Institute, the National Academies of Sciences, and the National Institute on Drug Abuse,” Sens. Orrin Hatch (R-Utah.) and Kamala Harris (D-Calif.) wrote in a letter. 

Sessions, who has been a strong critic of marijuana use, has questioned the medicinal benefits of the drug. 

Despite Sessions's hard-line stance on marijuana, the DEA has signaled it is open to research into medicinal uses of the drug. 

The agency altered its policy roughly two years ago to allow for more suppliers because of the growing interest in researching more medical uses for the drug.